Filing Details

Accession Number:
0001209191-20-065544
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-30 17:10:58
Reporting Period:
2020-12-28
Accepted Time:
2020-12-30 17:10:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808158 Repare Therapeutics Inc. RPTX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1815366 Michael Zinda C/O Repare Therapeutics Inc.
7210 Frederick-Banting, Suite 100
St-Laurent A8 H4S 2A1
Evp, Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-28 48 $2.06 85,277 No 4 M Direct
Common Stock Disposition 2020-12-28 14,726 $34.24 70,551 No 4 S Direct
Common Stock Disposition 2020-12-28 322 $34.60 70,229 No 4 S Direct
Common Stock Disposition 2020-12-29 14,539 $33.30 55,690 No 4 S Direct
Common Stock Disposition 2020-12-29 4,207 $34.63 51,483 No 4 S Direct
Common Stock Disposition 2020-12-29 950 $35.01 50,533 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2020-12-28 48 $0.00 48 $2.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
54,850 2029-03-29 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.60 to $34.58 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4).
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.94 to $33.89 inclusive.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.86 inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.04 inclusive.
  5. Twenty-five percent (25%) of the shares subject to the option vested on March 29, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.